• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Friday 07/20/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Electroceuticals

  • 6:56 PM

    Financing to be Used for the Development of a Portfolio of Treatments for Vascular Diseases and Ischemic Injuries Using Endonovo’s Immunotronics Platform LOS ANGELES, CA–ENDV, (Marketwired – Nov 28, 2016) – Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”), a developer of non-invasive electroceuticals for the treatment of inflammatory conditions and diseases in vital organs, today announced that it has signed a term sheet with a single strategic healthcare investor for $5 million in Series B Preferred Stock financing

    Read more
  • 2:25 PM

    Key Patent Covers Production of Human Proteins Used as Biologics, including EPO, G-CSF, GM-CSF, and IL-2 LOS ANGELES, CA– ENDV, (Marketwired – Aug 9, 2016) – Endonovo Therapeutics, Inc. (OTCQB: ENDV), a developer of bioelectronic devices and non-invasive Electroceuticals for the treatment of inflammatory conditions in vital organs, announced today that the U.S. Patent and Trademark Office issued U.S. Patent No. 9,410,143 covering the use of electromagnetic stimulation of cells to produce biological molecules. This newly-issued patent covers the production

    Read more
  • 3:14 PM

    Acquisition of RGN’s Electroceutical(TM) Product Portfolio and Intellectual Property LOS ANGELES, CA– ENDV, (Marketwired – Jul 11, 2016) – Endonovo Therapeutics, Inc. (OTCQB: ENDV) — a developer of bioelectronic devices and medicines, announced today it has executed a binding letter of intent (LOI) to acquire Rio Grande Neurosciences, Inc. (RGN), a privately-held clinical stage developer of non-invasive Electroceuticals™ for the treatment of neuro-inflammation and central nervous system diseases and disorders. The LOI is binding, but subject to the execution of

    Read more
  • 1:34 PM

    MIAMI, FL–(Marketwired – Jun 16, 2014) –  Amazonas Florestal, Ltd. (PINKSHEETS: AZFL) (“Amazonas” or “Company”), a diversified forest management company generating profit through innovative, sustainable forest management, is excited to announce that it recently delivered 185,787m3 of piquia sleepers (railroad ties) for use in the fulfillment of a standing $2,650,000 purchase order for Trackwork Ltd. (“Trackwork”), the largest contractor for railway supply in the United Kingdom. This delivery of hardwood sleepers (railroad ties) represents a small portion — 10 out of 200 total containers

    Read more
Public Wire Banner